Repligen Corporation Is A Global Life Sciences Company That Specializes In Bioprocessing Technologies For Biologic Drug Manufacturingfounded In 1981 By Pioneering Scientiststhe Company Is Headquartered In Walthammassachusettsand Operates Worldwide With Facilities In The U S Europeand Asiarepligen Develops Consumable Products And Systems That Enhance The Production Of Biological Drugs The Company S Product Portfolio Includes Upstream And Downstream Bioprocessing Technologies Such As Filtration Systemschromatography Productsfluid Management Solutionsand Cell Culture Supplementsrepligen Also Offers Technical Servicesincluding Installationcalibrationand Custom Bioprocessing Solutionsits Technologies Are Essential For Manufacturing Monoclonal Antibodiesgene Therapiesand Vaccinesserving Biopharmaceutical Developers And Contract Development And Manufacturing Organizations Globally Repligen Has Expanded Its Capabilities Through Strategic Acquisitions And Partnershipsfocusing On Innovation To Meet The Growing Demand For Biologicsthe Company Aims To Be A Trusted Partner In Bioprocessinghelping To Reduce Costs And Timelines For Biologic Drug Development While Ensuring Compliance With Regulatory Standards
United States
